PRICE T ROWE ASSOCIATES INC /MD/
Position in FLNA — Filana Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in FLNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$53,011
-$9,097 QoQ
Shares Held
31,368
0.0% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FLNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,301,022,166 across 256 Biotechnology names. FLNA ranks #250 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in FLNA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,011 | 31,368 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $62,108 | 31,368 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $64,921 | 35,868 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $47,140 | 31,427 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $85,823 | 36,366 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,039,879 | 35,334 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $429,582 | 34,784 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $635,624 | 31,327 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $672,396 | 29,871 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $459,080 | 27,589 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $655,149 | 26,719 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $650,444 | 26,967 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $750,345 | 25,401 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,161,801 | 27,781 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $755,078 | 26,852 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,049,019 | 28,245 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,000,773 | 22,901 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,319,944 | 21,262 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,871,904 | 21,909 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,604,984 | 35,706 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $92,049 | 13,497 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||